<bill session="119" type="h" number="124" updated="2025-03-19T16:00:15Z">
  <state datetime="2025-01-03">REFERRED</state>
  <status>
    <introduced datetime="2025-01-03"/>
  </status>
  <introduced datetime="2025-01-03"/>
  <titles>
    <title type="display">Byron Nash Renal Medullary Carcinoma Awareness Act of 2023</title>
    <title type="short" as="introduced">Byron Nash Renal Medullary Carcinoma Awareness Act of 2023</title>
    <title type="official" as="introduced">To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have sickle cell disease.</title>
  </titles>
  <sponsor bioguide_id="G000553"/>
  <cosponsors/>
  <actions>
    <action datetime="2025-01-03">
      <text>Introduced in House</text>
    </action>
    <action datetime="2025-01-03" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Cancer"/>
    <term name="Digestive and metabolic diseases"/>
    <term name="Health promotion and preventive care"/>
    <term name="Medicaid"/>
  </subjects>
  <amendments/>
  <summary date="2025-03-18T16:16:45Z" status="Introduced in House">Byron Nash Renal Medullary Carcinoma Awareness Act of 2023&#160;[sic]

This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)</summary>
</bill>
